SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates Against Symptomatic Infection

Amy J. Schuh, Panayampalli S. Satheshkumar, Stephanie Dietz, Lara Bull-Otterson, Myrna Charles, Chris Edens, Jefferson M. Jones, Kristina L. Bajema, Kristie E.N. Clarke, L. Clifford McDonald, Sadhna Patel, Kendra Cuffe, Natalie J. Thornburg, Jarad Schiffer, Kelly Chun, Monique Bastidas, Manory Fernando, Christos J. Petropoulos, Terri Wrin, Suqin Cai, Dot Adcock, Deborah Sesok-Pizzini, Stanley Letovsky, Alicia M. Fry, Aron J. Hall, Adi V. Gundlapalli
doi: https://doi.org/10.1101/2021.11.24.21266812

Data Availability

All data produced in the present work are contained in the manuscript.

Back to top
Posted November 26, 2021.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates Against Symptomatic Infection
Amy J. Schuh, Panayampalli S. Satheshkumar, Stephanie Dietz, Lara Bull-Otterson, Myrna Charles, Chris Edens, Jefferson M. Jones, Kristina L. Bajema, Kristie E.N. Clarke, L. Clifford McDonald, Sadhna Patel, Kendra Cuffe, Natalie J. Thornburg, Jarad Schiffer, Kelly Chun, Monique Bastidas, Manory Fernando, Christos J. Petropoulos, Terri Wrin, Suqin Cai, Dot Adcock, Deborah Sesok-Pizzini, Stanley Letovsky, Alicia M. Fry, Aron J. Hall, Adi V. Gundlapalli
medRxiv 2021.11.24.21266812; doi: https://doi.org/10.1101/2021.11.24.21266812
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area